Hikma Pharmaceuticals (HIK) Ordinary GBP 0.10
24.50p
(1.30%)
- Add to watchlist
- Create an alert
- This stock can be held in a
24.50p
(1.30%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
24.50p
(1.30%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
1,899.00p
1,925.00p
2,212.00p
£4.64 bn
1,889.50p
1,880.50p
1,491.50p
18.02
0.50p (0.03%) Previous:
0.50p
274,051
1.54%
1,000
Performance
| 1 week 1W | 1.09% | 1 year 1Y | 13.42% |
|---|---|---|---|
| 1 month 1M | 5.48% | 2 years 2Y | 101.47% |
| 3 months 3M | 3.16% | 3 years 3Y | 13.12% |
| 6 months 6M | 19.07% | 5 years 5Y | 5.81% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2018 | 31/12/2017 |
|---|---|---|
| Revenue ($m) | 2,070.00 | 1,936.00 |
| Profit before tax ($m) | 293.00 | (738.00) |
| Adjusted EPS (¢): | 137.80 | 105.00 |
| P/E ratio | 16.40 | 14.20 |
| PEG | 0.50 | n/a |
| EPS growth (%) | 31.00 | (11.00) |
Values are quoted in the stock's local currency: US dollar
All fundamental dataRecent dividends paid or declared by Hikma Pharmaceuticals:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| Interim | 22/08/2019 | 23/09/2019 | 14.00¢ |
| Final | 04/04/2019 | 22/05/2019 | 26.00¢ |
| Interim | 23/08/2018 | 21/09/2018 | 12.00¢ |
| Final | 05/04/2018 | 24/05/2018 | 23.00¢ |
| Interim | 24/08/2017 | 22/09/2017 | 11.00¢ |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual Hikma Pharmaceuticals dividends:
| Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
|---|---|---|---|
| 31/12/2018 | 1.70% | 3.63 | $0.38 |
| 31/12/2017 | 2.30% | 3.09 | $0.34 |
| 31/12/2016 | 1.30% | 3.59 | $0.33 |
| 31/12/2015 | 1.10% | 4.49 | $0.32 |
| 31/12/2014 | 0.80% | 6.86 | $0.32 |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyReady to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
-
Strong Sell
(0 of 7) -
Sell
(1 of 7) -
Neutral
(4 of 7) -
Buy
(0 of 7) -
Strong Buy
(2 of 7)
This is not a recommendation, it represents the consensus view of a basket of brokers. If fewer than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.
Full broker forecasts-
Hikma responds to FDA concerns over 'Advair Diskus' generic
27 November 2019 07:32
-
Hikma Pharmaceuticals maintains guidance as it invests in growth
7 November 2019 07:49
-
FTSE 250 movers: Sirius plummets, Sophos climbs
17 September 2019 15:02
-
Total Voting Rights
2 December 2019 17:12
-
Hikma completes FDA response for generic Advair®
27 November 2019 07:00
-
Director/PDMR Shareholding
21 November 2019 14:47
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.